Changes to the website
Sponsored By
Medicenna Trial
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4951

Next 25
Website Changes
02/23/2017 Tocagen Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Toca 511 & Toca FC in Recurrent High Grade Glioma
02/22/2017 UPDATED: Agenus’ lead cancer vaccine flops, investigators read last rites over glioblastoma PhII
02/21/2017 Help us better Understand Patient Experiences with Glioblastoma Multiforme
02/09/2017 VBI Vaccines Building On Duke University Research for New Cancer Therapy
02/09/2017 TRACON Pharmaceuticals Announces Top-line Results from NCI-Sponsored Phase 2 Trial of TRC105 in Recurrent Glioblastoma
02/09/2017 Trials Open for Enrollment: Phase II Study of VAL-083 in Patients with MGMT-unmethylated Bevacizumab-naïve Recurrent Glioblastoma Multiforme
02/07/2017 DelMar Pharmaceuticals Inc (DMPI) Moves Forward With Flagship Chemotherapy Into Phase II
02/06/2017 NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA
02/04/2017 17th Annual UCLA Brain Tumor Conference
02/04/2017 Optimism and Opportunity as we Initiate Clinical Trials for MGMT-unmethylated GBM Patients at MD Anderson
02/04/2017 Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
02/04/2017 FDA Grants New Clearance for Brain Surgery Technology
02/04/2017 Northwell Health is First on Long Island to Acquire Synaptive Medical’s BrightMatter™ Technology for Complex Brain Tumor and Spinal Surgery
02/04/2017 Researchers at Yale have taken steps toward a ‘completely unexpected’ new way to treat brain cancer
02/04/2017 New Brain Cancer Coalition Announces Precision Medicine Study During CHOP Event
01/28/2017 The Musella Foundation announced that it has awarded a $25,000 brain tumor research grant
01/26/2017 Out of Warburg Effect: an effective cancer treatment targeting the tumor specific metabolism and dysregulated pH.
01/25/2017 Correction to: Brain Surgery Made Safer With New Smart Needle
01/25/2017 DelMar Pharmaceuticals and MD Anderson Initiate New Phase Two Clinical Trial of VAL-083 for MGMT-unmethylated Recurrent Glioblastoma Multiforme (GBM)
01/25/2017 ‘Tumor Shrinking’ Drug Shows Promise In Dogs Before Clinical Trials On Humans
01/25/2017 Antiangiogenic treatments prolong OS in glioblastoma subgroup
01/25/2017 Combination therapy for glioblastoma shows promising results in early-stage research
01/24/2017 Norton, UK Partner on Clinical Trial for First-Ever Treatment of Radiation Necrosis
01/24/2017 Quick Survey For GBM patients
01/24/2017 Brain Surgery Made Safer With New Smart Needle



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites